The global blarcamesine market comprises drugs that help enhance cognitive abilities and provide neuroprotective benefits. Blarcamesine is an orally administered brain-derived neurotrophic factor inducer that helps promote neuronal survival, growth, and maintenance. It shows potential in treating various neurological diseases such as Alzheimer's, dementia, Parkinson's, and depression. The drug...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian